Literature DB >> 8014504

Use of serology to diagnose pneumonia caused by nonencapsulated Haemophilus influenzae and Moraxella catarrhalis.

L A Burman1, M Leinonen, B Trollfors.   

Abstract

Antibodies against nonencapsulated Haemophilus influenzae and Moraxella (Branhamella) catarrhalis were measured by ELISA in paired sera from 158 adult patients with pneumonia. A mixture of 10 clinical isolates of each species was used as antigen. Eleven patients (7%) showed significant increases in antibody to H. influenzae. In 3 of them, the organism was isolated from transtracheal aspirate and in another 7 from sputum, nasopharynx, or both. Six patients with nonencapsulated H. influenzae in transtracheal aspirate cultures did not show any antibody increase. Six patients had significant increases in antibody to M. catarrhalis. The organism was isolated in transtracheal aspirates from 1 of them and in sputum and nasopharynx (or both) from another 3. Two patients with M. catarrhalis in transtracheal aspirate cultures showed no antibody response. In conclusion, the serologic methods increased the possibility to diagnose infections caused by the two agents but had low sensitivity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8014504     DOI: 10.1093/infdis/170.1.220

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Bactericidal monoclonal antibody against Moraxella catarrhalis lipooligosaccharide cross-reacts with Haemophilus Spp.

Authors:  Raina T Gergova; Ianko D Iankov; Iana H Haralambieva; Ivan G Mitov
Journal:  Curr Microbiol       Date:  2007-01-05       Impact factor: 2.188

2.  Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients.

Authors:  D Lieberman; M Ben-Yaakov; Z Lazarovich; A Porath; F Schlaeffer; D Lieberman; M Leinonen; P Saikku; O Horovitz; I Boldur
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

3.  Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines.

Authors:  W S Lim; J T Macfarlane; T C Boswell; T G Harrison; D Rose; M Leinonen; P Saikku
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

4.  Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients.

Authors:  D Lieberman; F Schlaeffer; I Boldur; D Lieberman; S Horowitz; M G Friedman; M Leiononen; O Horovitz; E Manor; A Porath
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

Review 5.  Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.

Authors:  T F Murphy
Journal:  Microbiol Rev       Date:  1996-06

6.  Human immune response against outer membrane proteins of Moraxella (Branhamella) catarrhalis determined by immunoblotting and enzyme immunoassay.

Authors:  M E Helminen; R Beach; I Maciver; G Jarosik; E J Hansen; M Leinonen
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

7.  Galactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination.

Authors:  Shengqing Yu; Hang Xie; Anup Datta; Natasha Naidu; Xin-Xing Gu
Journal:  Infect Immun       Date:  2008-06-16       Impact factor: 3.441

8.  Viruses and bacteria in the etiology of the common cold.

Authors:  M J Mäkelä; T Puhakka; O Ruuskanen; M Leinonen; P Saikku; M Kimpimäki; S Blomqvist; T Hyypiä; P Arstila
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

9.  A comparative study of the etiology of adult upper and lower respiratory tract infections in the community.

Authors:  David Lieberman; Devora Lieberman; Igor Korsonsky; Miriam Ben-Yaakov; Zilia Lazarovich; Maureen G Friedman; Bella Dvoskin; Maija Leinonen; Bella Ohana; Ida Boldur
Journal:  Diagn Microbiol Infect Dis       Date:  2002-01       Impact factor: 2.803

10.  Bacterial coinfections in children with viral wheezing.

Authors:  P Lehtinen; T Jartti; R Virkki; T Vuorinen; M Leinonen; V Peltola; A Ruohola; O Ruuskanen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-07       Impact factor: 3.267

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.